BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
32990384
Number of visits today
2764
Number of downloads
16170351
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Cheng Y, Tang R, Li X, Wang B, Cheng Y, Xiao S, Sun P, Yu W, Li C, Lin X, Zhu Y. LRP1B is a Potential Biomarker for Tumor Immunogenicity and Prognosis of HCC Patients Receiving ICI Treatment. JHC 2022;Volume 9:203-20. [DOI: 10.2147/jhc.s348785] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu F, Cui WQ, Liu C, Feng F, Liu R, Zhang J, Sun CG. Prognostic biomarkers correlated with immune infiltration in non-small cell lung cancer. FEBS Open Bio 2023;13:72-88. [PMID: 36282125 DOI: 10.1002/2211-5463.13501] [Reference Citation Analysis]
2 Conconi D, Jemma A, Giambra M, Redaelli S, Croci GA, Dalprà L, Lavitrano M, Bentivegna A. Analysis of copy number alterations in bladder cancer stem cells revealed a prognostic role of LRP1B. World J Urol 2022. [PMID: 35841413 DOI: 10.1007/s00345-022-04093-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Yu G, Mu H, Fang F, Zhou H, Li H, Wu Q, Xiong Q, Cui Y. LRP1B mutation associates with increased tumor mutation burden and inferior prognosis in liver hepatocellular carcinoma. Medicine (Baltimore) 2022;101:e29763. [PMID: 35777027 DOI: 10.1097/MD.0000000000029763] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345